Serviceprovider for pharmaceutical industry, quality management (ISO9001, ISO13485, ISO15224, ISO14971), non-interventional studies, data privacy (GDPR), validation, qualification
M-B-V-C offers expert venture management and strategy consulting for entrepreneurs and executives in tech- and innovation-driven startups and intrapreneurial business ventures towards company success.
Unlock efficiency in your exploration and exploitation activities through expert advice on your strategy, business plan, team building, fundraising, business development, scaling and company development towards successful commercialisation.
#HelpingVenturesTakeFlight
#venture #biotech #biopharma #deeptech #innovation #commercialisation #success #exploration #exploitation #ambidexterity #m-b-v-c
medupha ist Experte für healthcare Marktforschung. Mit einem Team aus Pharma-/Healthcare Expert:innen, Psycholog:innen und Marktforschungsexpert:innen setzt das Institut Ärztebefragungen, Patientenumfragen und Bevölkerungsumfragen für verschiedene stakeholder im Gesundheitswesen um (Pharma, Medizintechnik, Biotech, öffentlicher Sektor, Gesundheitsdienstleister, .. ). Das Institut analysiert Märkte, Therapiegewohnheiten, Patientenmeinungen und hat 50 Jahre Expertise in Methodik, Analyse und Beratung. Zwei qualifizierte eigene Befragungspools (Ärzte, Patient:innen - www.patietenstimme.eu) garantieren Zugang zu relevanten Zielgruppen.
The objective of Health Hub Tirol, an initiative of the State of Tyrol, is to promote innovation in the fields of life sciences, medical technology, e-health, pharmaceuticals and biotechnology and to further enhance Tyrol’s profile as an internationally recognised healthcare industry location boasting many successful companies. The initiative aims to facilitate not only the founding of life science companies in Tyrol, but also to encourage businesses to locate here and/or to establish and develop their business model in the region.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
EDE – Your partner for successful studies and research. Smart monitoring of health in everyday life through personalized questioning via app and simultaneous measurement using a wearable for optimal support of probands.